Ruth L. Goodall
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial.
Journal: PLOS global public health
Published: August 22, 2025
A comparative study of pharyngolaryngectomy free flap reconstruction: A 12-year retrospective analysis at a single center.
Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS
Published: July 22, 2025
Long-term non-progression in children with HIV: estimates from international cohort data.
Journal: AIDS (London, England)
Published: August 22, 2024
Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis.
Journal: Tropical medicine and infectious disease
Published: August 05, 2024
Treatment outcomes in people with diabetes and multidrug-resistant tuberculosis (MDR TB) enrolled in the STREAM clinical trial.
Journal: PLOS global public health
Published: July 24, 2024
Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.
Journal: The Lancet. Respiratory medicine
Published: March 18, 2024
A publicly accessible global data repository - the WHO TB-IPD platform.
Journal: IJTLD open
Published: March 17, 2024
T-wave morphology abnormalities in the STREAM stage 1 trial.
Journal: Expert opinion on drug safety
Published: March 11, 2024
Radiographic characteristics of rifampicin-resistant tuberculosis in the STREAM stage 1 trial and their influence on time to culture conversion in the short regimen.
Journal: BMC infectious diseases
Published: June 14, 2023
ECG monitoring in STREAM Stage 1: can we identify those at increased risk of QT prolongation?
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: October 25, 2022
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Journal: Lancet (London, England)
Published: August 26, 2022
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: July 28, 2022
Last Updated: 09/26/2026